Literature DB >> 14676447

Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population.

Hoon Han1, Chul-Woo Pyo, Do-Sung Yoo, Pil-Woo Huh, Kyung-Souk Cho, Dal-Soo Kim.   

Abstract

Moyamoya disease is characterized by progressive cerebrovascular occlusion at the peripheral internal carotid artery and development of abnormal collateral circulation at the cerebral basal region. Although abnormal thrombogenesis, inflammation and autoimmune process might be involved in the etiology, the genetic pathogenesis of Moyamoya disease is still unknown. To evaluate the association of Moyamoya disease with HLA alleles in the Korean population, we investigated HLA class I and class II alleles in 28 Moyamoya patients and 198 unrelated healthy controls. The frequency of HLA-B35 allele was significantly increased in the patients compared to the controls (32.1% vs. 10.1%, RR=4.2, p<0.008). Further analysis of HLA-B35 on onset age and sex showed that this allele was significantly increased compared to the controls in both late-onset and female group. Especially, HLA-B35 was the most significantly increased in female of late-onset group compared to the controls. These results suggest that HLA-B35 may be an useful genetic marker for Moyamoya disease, and particularly in females of late onset group in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14676447      PMCID: PMC3055136          DOI: 10.3346/jkms.2003.18.6.876

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  18 in total

Review 1.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

2.  Age-specific eNOS polymorphisms in moyamoya disease.

Authors:  Young Seok Park; Kyung Tae Min; Tae-Gon Kim; Yun Ho Lee; Hee Jin Cheong; In Sun Yeom; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2011-06-21       Impact factor: 1.475

3.  The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; In Bo Han; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

4.  Association of HLA-DR and -DQ Genes with Familial Moyamoya Disease in Koreans.

Authors:  Seok Ho Hong; Kyu-Chang Wang; Seung-Ki Kim; Byung-Kyu Cho; Myoung Hee Park
Journal:  J Korean Neurosurg Soc       Date:  2009-12-31

5.  The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.

Authors:  Xun-Sha Sun; Jun Wen; Jiao-Xing Li; Rong Lai; Yu-Fang Wang; Hui-Jiao Liu; Wen-Li Sheng
Journal:  Mol Genet Genomics       Date:  2016-02-05       Impact factor: 3.291

6.  The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; Kyu Young Chae; Seung-Hun Oh; In Bo Han; Hyun Sook Kim; Won-Chan Kim; Ok-Joon Kim; Tae Gon Kim; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

7.  HLA and Disease Associations in Koreans.

Authors:  Stephen Ahn; Hee-Back Choi; Tai-Gyu Kim
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

Review 8.  Moyamoya Biomarkers.

Authors:  Edward R Smith
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 9.  Single Nucleotide Polymorphism in Patients with Moyamoya Disease.

Authors:  Young Seok Park
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 10.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.